クローナル細胞減少症(意義不明)患者のリスクスコアリングモデルにおける明確な利点
Yazan Jabban1, Rong He2, Kurt Bessonen3
1Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
British journal of haematology
|February 25, 2026
まとめ
No abstract available in PubMed .
さらに関連する動画
関連する概念動画
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
502
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
502
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
578
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
578


